Breast Cancer Prognosis and Steroid Receptor Content
Author Information
Author(s): C. Kamby, J. Andersen, B. Ejlertsen, N.E. Birkler, L. Rytter, K. Zedeler, S.M. Thorpe, T. N0rgaard, C. Rose
Primary Institution: The Finsen Institute, Rigshospitalet, Copenhagen
Hypothesis
The study examines the relationship between histological grade, steroid receptor content, and prognosis in breast cancer patients.
Conclusion
Patients with well-differentiated tumors or high steroid receptor content have better survival outcomes.
Supporting Evidence
- Patients with low differentiated tumors had a shorter overall survival than those with higher differentiated tumors.
- Prolonged recurrence-free interval and overall survival were associated with increasing steroid receptor concentrations.
- High steroid receptor content was linked to a propensity for recurrence in bone.
Takeaway
This study found that how aggressive a breast cancer is and how many hormone receptors it has can help predict how well a patient will do.
Methodology
The study analyzed data from patients enrolled in the DBCG-77 protocols, focusing on tumor differentiation and steroid receptor content.
Potential Biases
Histological grading techniques involve subjectivity, which may introduce variability.
Limitations
Only 15% of patients had steroid receptor data, which may limit the findings.
Participant Demographics
The study included 863 patients with clinical recurrence, with a median follow-up of 4.9 years.
Statistical Information
P-Value
p=0.0001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website